Conference
18LBA A GCIG randomized phase III study of carboplatin (C) & pegylated liposomal doxorubicin (PLD) (C-D) vs carboplatin (C) & paclitaxel (P) (C-P): CALYPSO results in partially platinum-sensitive ovarian cancer (OC) patients
Authors
Vasey P; Largillier R; Gropp M; Gebski V; Sandvei R; Elit L; Angleitner-Boubezinek L; Reed N; Pignata S; Ferrero AM
Volume
7
Publisher
Elsevier
Publication Date
September 2009
DOI
10.1016/s1359-6349(09)72053-1
Conference proceedings
European Journal of Cancer Supplements
Issue
3
ISSN
1359-6349